These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 820172)

  • 1. Chemical models and chemotherapy in the sphingolipidoses.
    Radin NS
    Adv Exp Med Biol; 1976; 68():453-72. PubMed ID: 820172
    [No Abstract]   [Full Text] [Related]  

  • 2. [Brain cerebrosides].
    Promyslov MSh; Popova GM
    Vopr Med Khim; 1972; 18(3):227-40. PubMed ID: 4212568
    [No Abstract]   [Full Text] [Related]  

  • 3. Sphingolipids.
    Stoffel W
    Annu Rev Biochem; 1971; 40():57-82. PubMed ID: 4941240
    [No Abstract]   [Full Text] [Related]  

  • 4. The association of the galactosyl diglycerides of brain with myelination. II. The inability of the myelin-deficient mutant, jimpy mouse, to synthesize galactosyl diglycerides effectively.
    Deshmukh DS; Inoue T; Pieringer RA
    J Biol Chem; 1971 Sep; 246(18):5695-9. PubMed ID: 5096090
    [No Abstract]   [Full Text] [Related]  

  • 5. Treating glucosphingolipid disorders by chemotherapy: use of approved drugs and over-the-counter remedies.
    Radin NS
    J Inherit Metab Dis; 2000 Dec; 23(8):767-77. PubMed ID: 11196103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Disturbances of the lipid metabolism in relation to the nervous system. II. Sphingolipids and sphingolipidoses].
    Tichý J
    Cesk Neurol; 1973 Jan; 36(1):51-60. PubMed ID: 4685128
    [No Abstract]   [Full Text] [Related]  

  • 7. Cancer and sphingolipid storage disease therapy using novel synthetic analogs of sphingolipids.
    Gatt S; Dagan A
    Chem Phys Lipids; 2012 May; 165(4):462-74. PubMed ID: 22387097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The biochemistry of sphingolipid storage diseases.
    Sandhoff K
    Angew Chem Int Ed Engl; 1977 May; 16(5):273-85. PubMed ID: 406814
    [No Abstract]   [Full Text] [Related]  

  • 9. Pathology and current treatment of neurodegenerative sphingolipidoses.
    Eckhardt M
    Neuromolecular Med; 2010 Dec; 12(4):362-82. PubMed ID: 20730629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enzyme defects in the sphingolipidoses and their application to diagnosis.
    Brady RO
    Ann Clin Lab Sci (1971); 1972; 2(4):285-94. PubMed ID: 4342099
    [No Abstract]   [Full Text] [Related]  

  • 11. A possible therapeutic approach to Krabbe's globoid leukodystrophy and the status of cerebroside synthesis in the disorder.
    Radin NS; Arora RC; Ullman MD; Brenkert AL; Austin J
    Res Commun Chem Pathol Pharmacol; 1972 May; 3(3):637-44. PubMed ID: 5034520
    [No Abstract]   [Full Text] [Related]  

  • 12. Deficiency of monogalactosyl diglycerid beta-B-galactosidase activity in krabbe's disease.
    Wenger DA; Satter M; Markey JP
    Biochem Biophys Res Commun; 1973 Jul; 53(2):680-5. PubMed ID: 4716994
    [No Abstract]   [Full Text] [Related]  

  • 13. Localized beta-galactosidase deficiency. Occurrence in cerebellar ataxia with myoclonus epilepsy and macular cherry-red spot--a new variant of GM1-gangliosidosis?
    Yamamoto A; Adachi S; Kawamura S; Takahashi M; Kitani T
    Arch Intern Med; 1974 Oct; 134(4):627-34. PubMed ID: 4278184
    [No Abstract]   [Full Text] [Related]  

  • 14. Enzyme replacement therapy for the sphingolipidoses.
    Brady RO; Pentchev PG; Gal AE; Hibbert SR; Quirk JM; Mook GE; Kusiak JW; Tallman JF; Dekaban AS
    Adv Exp Med Biol; 1976; 68():523-32. PubMed ID: 820173
    [No Abstract]   [Full Text] [Related]  

  • 15. Sphingolipidoses and allied disorders.
    Crocker AC
    Adv Exp Med Biol; 1976; 68():585-9. PubMed ID: 132847
    [No Abstract]   [Full Text] [Related]  

  • 16. Disorders of lipid metabolism.
    Brady RO
    Biochem J; 1972 Jun; 128(1):4P-6P. PubMed ID: 5085626
    [No Abstract]   [Full Text] [Related]  

  • 17. Substrate reduction therapy in mouse models of the glycosphingolipidoses.
    Platt FM; Jeyakumar M; Andersson U; Heare T; Dwek RA; Butters TD
    Philos Trans R Soc Lond B Biol Sci; 2003 May; 358(1433):947-54. PubMed ID: 12803928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances and novel treatments for sphingolipidoses.
    Arenz C
    Future Med Chem; 2017 Sep; 9(14):1687-1700. PubMed ID: 28857617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal transplantation in Type II Gaucher disease.
    Desnick SJ; Desnick RJ; Brady RO; Pentchev PG; Simmons RL; Najarian JS; Swaiman K; Sharp HL; Krivit W
    Birth Defects Orig Artic Ser; 1973 Mar; 9(2):109-19. PubMed ID: 4611522
    [No Abstract]   [Full Text] [Related]  

  • 20. [Sphingolipidoses: an overview].
    Suzuki K
    Tanpakushitsu Kakusan Koso; 1988 Apr; 33(5):718-20. PubMed ID: 3152093
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.